No Data
No Data
Sunshine Biopharma's Revenue Soars 54% in Q1
Express News | Sunshine Biopharma Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 EPS Results
Sunshine Biopharma Q1 EPS $(2.00) Misses $(1.04) Estimate, Sales $7.54M Beat $7.00M Estimate
Sunshine Biopharma (NASDAQ:SBFM) reported quarterly losses of $(2.00) per share which missed the analyst consensus estimate of $(1.04) by 92.31 percent. This is a 75 percent increase over losses of $(
Earnings Flash (SBFM) SUNSHINE BIOPHARMA Posts Q1 Revenue $7.5M
08:03 AM EDT, 05/21/2024 (MT Newswires) -- Earnings Flash (SBFM) SUNSHINE BIOPHARMA Posts Q1 Revenue $7.5M
Sunshine Biopharma Reports 2024 First Quarter Results: Revenues Up 54%
10-Q: Quarterly report
No Data